Replies to post #86952 on Ayala Pharmaceuticals Inc (ADXS)

[mortmann]

Not sure what time period you're talking about but ADXS carries an accumulated deficit of $349,000,000+ as of July 31 2018. Doesn't mean some measure of success won't be achieved at some point but clearly they've come up a little short thus far.